Does protein binding modulate the effect of angiotensin II receptor antagonists?

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue SUPPL. 1, 2001, Pages

  Maillard, Marc P ^a   Centeno, Catherine ^a   Frostell Karlsson, Åsa ^a,b   Brunner, Hans R ^a   Burnier, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b BIACORE AB   (Sweden)

Author keywords

AT1 receptor antagonists; Pharmacokinetic; Protein binding

Indexed keywords

EID: 0002146836     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/14703203010020010901     Document Type: Article

References (13)

1. Burnier M, Brunner HR. Angiotensin II receptor antagonist. Lancet 2000;355:637-45.
2. 1 receptor antagonists. Hypertension 1999;33:850-5.
3. Csajka C, Buclin T, Brunner HR, Biollaz J. Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists. Clin Pharmacokinet 1997;32:1-29.
4. Goldberg MR, Lo MW, Christ DD et al. DuP-532, an angiotensin II receptor antagonist: first administration and comparison with losartan. Clin Pharmacol Ther 1997;61:59-69.
5. 1 receptor antagonist. J Pharmacol Exp Ther 1991;259:861-70.
6. Chiu AT, Carini DJ, Duncia JV et al. DUP-532: a second generation of nonpeptide angiotensin II receptor antagonists. Biochem Biophys Res Comm 1991;177(1):209-17.
7. Maillard M, Mazzolai L, Daven V et al. Assessment of angiotensin II-receptor blockade in humans using a standardised angiotensin II-receptor binding assay. Am J Hypertens 1999;12:1201-8.
8. Maillard M, Rossat J, Nussberger J et al. Pharmacological profile of UR-7247, an orally active angiotensin II receptor antagonist in healthy volunteers. J Cardiovasc Pharmacol 2000;35:383-9.
9. Maillard M, Rossat J, Brunner HR, Burnier M. Tasosartan, enoltasosartan, and angiotensin II receptor blockade, the confounding role of protein binding. J Pharmacol Exp Ther 2000;295:649-54.
10. Sjöholm I, Ekman B, Kober A, Ljungstedt-Pahlman I, Seiving B, Sjödin T. Binding of drugs to human serum albumin XI: the specificity of three binding sites as studied with albumin immobilized in microparticles. Mol Pharmacol 1979;16:767-77.
11. Lama JJ, Haughey DB. Disopyramide binding to serum protein in man and animals. Drug Metab Disposit 1981;9:582-3.
12. 1) receptor blockers in hypertension. J Hum Hypertens 2000;14:S73-S86.
13. 1-receptor blockers in isolated vessels of different origin. Hypertension 1999;33:1406-13.